IL33846A - Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them - Google Patents
Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL33846A IL33846A IL33846A IL3384670A IL33846A IL 33846 A IL33846 A IL 33846A IL 33846 A IL33846 A IL 33846A IL 3384670 A IL3384670 A IL 3384670A IL 33846 A IL33846 A IL 33846A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- carbon
- pharmaceutically acceptable
- group containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1291864 Anti-asthmatic medicines FISONS PHARMACEUTICALS Ltd 2 Feb 1970 [12 Feb 1969] 7467/69 Heading ASB [Also in Division C2] Therapeutic compositions for the treatment 'extrinsic' and 'intrinsic' asthma, and other conditions, such as hay fever, urticaria and autoimmune diseases, in which antigen-antibody reactions are responsible for disease, by administration orally, parenterally or topically, or by inhalation, comprise compounds of formula: or their pharmaceutically acceptable derivatives (e.g. salts, esters or amides), wherein one of V and W is O, and the other is S; and P, Q, R, T are each H, halogen, C 1-10 alkyl, OH, alkoxy, hydroxyalkoxy, alkoxyalkoxy, AcO, CO 2 H, NH 2 , alkyl-NH, (alkyl) 2 N, alkenyl, aralkyl (up to C 10 ), Ph, NO 2 , carboxylic ester, alkenyloxy or acyl, or an adjacent pair of P, Q, R, T together with the adjacent carbon atoms in the benzene ring form a fused 5- or 6-membered carbocyclic or heterocyclic ring. For administration by inhalation, the compositions may include a bronchodilator such as isoprenaline, adrenaline, orciprenaline, isoetharine or their pharmaceutically acceptable derivatives.
[GB1291864A]
Claims (1)
1. 42 CLAMS Processes for the preparation of compounds of the formula in which and which may he the same or each represent an alkyl group containing from 1 to 10 carbon a alkoxy or carboxy the above groups containing up to 10 carbon a carbalkoxy or or an adjacent pair of R and together with the adjacent carbon atoms in the benzene ring may form a fused or 6 cyclic membered V and which are each represent oxygen or provided not all of and are when and are all hydrogen is not a chlorine when I is a methoxy and are 7 is oxygen and W is p is not a methyl when V is sulphur and is one of R and is alkoxy or an adjacent pair of R and T together with the adjacent carbon atoms of the benzene a 6 membered carbocyclic and pharmaceutically acceptable alkyl esters or unsubstituted amides which comprise producing a of formula in which T and the provisos are as defined by cyclising a compound of formula p in which T and the provisos are as defined and represents or an alkali producing a of formula in which provisos are defined by treating a corresponding compound of formula 44 or of P in which III and IV and the provisos are a defined and represents an alkali metal cation or an alkyl with phosphorous pentasulp and where desired converting the compound of I produced a acceptable derivative A process according to part of Claim wherein the cyclisation is carried out in the presence of a dehydrating A process according to part of Claim wherein the cyclisation is effected by converting the groups in the compound of formula II to acyl chloride groups and subjecting the resulting acyl chloride to an internal Friedel Crafts A process according to part of Claim wherein the reaction is carried out at elevated temperature in a solvent which is inert under the reaction A process as claimed in Claim 1 and substantially as hereinbefore described in any one of Examples 1 to A process for the production of a pharmaceutically acceptable salt of a compound of formula as defined in Claim which comprises converting the compound of formula a different salt an ester or an amide thereof to the desired 45 Compounds of formula I in Claim whenever produced by a process according to any one of Claims 1 to Compounds of formula as defined in Claim A compound of formula in which and the provisos are as defined in Claim A compound of formula in which and the provisos are as defined in Claim A compound according to any of Claims 8 to wherein R and which may be the same or each represent bromine or an alkyl group containing from 1 to 6 carbon a hydroxy an group containing from 1 to 10 carbon a carboxy a phenyl a nitro a carbalkoxy group containing from 1 to 6 carbon an group containing from 1 to 6 carbon or R and 46 together with adjacent carbon atoms in the benzene ring form the chains compound according to any of Claims 8 to in which R and which may be the same or each represent chlorine or a nitro or an or group containing from 1 to 6 carboy or an adjacent pair of and form an alkylene or A compound according to any of Claims 8 to wherein P represents lic lic A compound according to any one of Claims 8 to in the form of a pharmaceutically acceptable ester or amide 47 A compound according to any one of Claims 7 to in the form of the sodium salt lie ethyl Ethyl carbox A pharmaceutical composition comprising a compound o formula 48 which R and which may be the same or each represent an alkyl group containing from 1 to 10 carbon a alkoxy or carboxy the above groups containing up to 10 carbon a carbalkoxy or alkenyloxy or an adjacent pair of R and together with the adjacent carbon atoms in the benzene ring may form a fused or 6 cyclic V and which are each Kpresent oxygen or except V is sulphur and W is oxygen one of R and T is alkoxy or an adjacent pair of and T together with the adjacent Carbon atoms of the a 6 membered carbocyclic rin or a pharmaceutically acceptable alkyl ester or unsubstituted amide as active in combinati with a pharmaceutically acceptable diluent or A composition according to Claim wherein the compound of formula I c is a compound according to any one of Claims 7 to A composition according to either of Claims 38 and incorporating a b ronchodilator A composition according to any of Claims 38 to in a form suitable for administration of a dose of from to 50 mgs of active A pharmaceutical composition according to Claim substantially as hereinbefore 49 A composition according to any of Claims 40 and the active ingredient is one of the compounds of 27 to A composition according to any of Claims 40 and wherein the active ingredient is one of the compounds of Claims 30 to composition according to any of Claims 40 and wherein the active ingredient is the compound of Claim insufficientOCRQuality
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7467/69A GB1291864A (en) | 1969-02-12 | 1969-02-12 | Mono thiachromone-2-carboxylic acids |
Publications (2)
Publication Number | Publication Date |
---|---|
IL33846A0 IL33846A0 (en) | 1970-04-20 |
IL33846A true IL33846A (en) | 1976-04-30 |
Family
ID=9833661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL33846A IL33846A (en) | 1969-02-12 | 1970-02-05 | Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them |
Country Status (9)
Country | Link |
---|---|
JP (2) | JPS4835267B1 (en) |
CH (5) | CH551437A (en) |
DE (1) | DE2006196A1 (en) |
DK (1) | DK128420B (en) |
FR (1) | FR2034538B1 (en) |
GB (1) | GB1291864A (en) |
IL (1) | IL33846A (en) |
NL (1) | NL7001922A (en) |
SE (1) | SE367634B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1362782A (en) * | 1970-08-26 | 1974-08-07 | Fisons Ltd | Tetrazole derivatives |
BE769146A (en) * | 1970-07-01 | 1971-11-03 | Takeda Chemical Industries Ltd | CHROMON-CARBOXYLIC ACID DERIVATIVES |
GB1391615A (en) * | 1971-09-30 | 1975-04-23 | Fisons Ltd | 4-oxo-4h-1-benzopyran and 4-oxo-4h-1-thia benzopyran derivatives |
JPS50112055U (en) * | 1974-02-22 | 1975-09-12 | ||
US4159273A (en) * | 1974-11-30 | 1979-06-26 | Fisons Limited | Tricyclic mono-chromone-2-carboxylic acids |
AT351530B (en) * | 1974-11-30 | 1979-07-25 | Fisons Ltd | PROCESS FOR THE PREPARATION OF NEW PYRAN-2-CARBONIC ACIDS, THEIR SALT, ESTER, AMIDES AND OPTICAL ISOMERS |
ATE25251T1 (en) * | 1981-11-12 | 1987-02-15 | Fisons Plc | ANTI SRS-A CARBONIC ACID DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM. |
US4665203A (en) * | 1983-08-08 | 1987-05-12 | G. D. Searle & Co. | Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors |
US4888356A (en) * | 1983-08-08 | 1989-12-19 | G. D. Searle And Company | Use of substituted dihydrobenzopyrans for allergy and inflammation |
US4778903A (en) * | 1983-12-12 | 1988-10-18 | G. D. Searle & Co. | Substituted dihydrobenzopyrans |
US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
US4644071A (en) * | 1984-07-11 | 1987-02-17 | G. D. Searle & Co. | Aralkoxy and aryloxyalkoxy kojic acid derivatives |
-
1969
- 1969-02-12 GB GB7467/69A patent/GB1291864A/en not_active Expired
-
1970
- 1970-02-05 IL IL33846A patent/IL33846A/en unknown
- 1970-02-10 FR FR7004568A patent/FR2034538B1/fr not_active Expired
- 1970-02-11 DK DK66870AA patent/DK128420B/en unknown
- 1970-02-11 NL NL7001922A patent/NL7001922A/xx unknown
- 1970-02-11 CH CH196970A patent/CH551437A/en not_active IP Right Cessation
- 1970-02-11 CH CH178472A patent/CH557811A/en not_active IP Right Cessation
- 1970-02-11 DE DE19702006196 patent/DE2006196A1/en active Pending
- 1970-02-11 CH CH178672A patent/CH557346A/en not_active IP Right Cessation
- 1970-02-11 CH CH178572A patent/CH560712A5/xx not_active IP Right Cessation
- 1970-02-11 CH CH178372A patent/CH551438A/en not_active IP Right Cessation
- 1970-02-11 SE SE01744/70A patent/SE367634B/xx unknown
-
1972
- 1972-08-25 JP JP47084684A patent/JPS4835267B1/ja active Pending
- 1972-08-25 JP JP47084683A patent/JPS4835266B1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2034538B1 (en) | 1974-08-30 |
DE2006196A1 (en) | 1970-11-05 |
NL7001922A (en) | 1970-08-14 |
FR2034538A1 (en) | 1970-12-11 |
DK128420B (en) | 1974-04-29 |
CH551437A (en) | 1974-07-15 |
CH557811A (en) | 1975-01-15 |
CH560712A5 (en) | 1975-04-15 |
JPS4835266B1 (en) | 1973-10-26 |
IL33846A0 (en) | 1970-04-20 |
JPS4835267B1 (en) | 1973-10-26 |
SE367634B (en) | 1974-06-04 |
GB1291864A (en) | 1972-10-04 |
CH557346A (en) | 1974-12-31 |
CH551438A (en) | 1974-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1087205A (en) | 2-amino-3-(5-and 6-)benzoylphenylacetic acids, esters and metal salts thereof | |
US4440785A (en) | Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation | |
JPS6354321A (en) | Blood sugar lowering agent | |
IL33846A (en) | Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them | |
US3853923A (en) | 2-substituted-(2-hydroxy-3-lower alkaminopropoxy)-benzofurans | |
US3506667A (en) | Furo quinoline carboxylates | |
US4389408A (en) | Novel ampicillin esters and production thereof | |
SE7705637L (en) | PROCEDURE FOR THE PREPARATION OF DIBENSOXEPIN DERIVATIVES WITH THERAPEUTIC EFFECT | |
HUT46895A (en) | Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect | |
GB1355147A (en) | Oxoprostanoic acid derivatives | |
US3740437A (en) | Naphthyloxyacetic acids and pharmaceutical compositions and methods thereof | |
IE36716B1 (en) | Substituted cyclic urea derivatives and pharmaceutical compositions containing them | |
GB1353304A (en) | Process for production of diketopiperazine dihydroxamates and intermediate therefor | |
CH640526A5 (en) | METHOD FOR PRODUCING NEW BENZOPYRANE DERIVATIVES. | |
ES8401926A1 (en) | Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same. | |
US3647802A (en) | 2-amino-4-aryl-3 4-dihydroquinolines | |
US3714206A (en) | Benzo-2,3,1-diazaborines | |
EP0000488A1 (en) | 3-Oxaloamino-4-oxo-4H-1-benzopyrane compounds, process for their preparation and their pharmaceutical use | |
US4018818A (en) | Hydroxyl-substituted 2-chloro-α-(tert-butylaminomethyl)-benzylalcohols | |
US3457273A (en) | Derivative of phenylbutazone | |
GB1384843A (en) | Benzofuran derivatives their preparation and compositions containing them | |
IE33870B1 (en) | Benzobenzofuranooxepine compounds and process for preparing the same | |
US3169127A (en) | Derivatives of penicillin amides | |
US3184463A (en) | Piperazines and method of making same | |
US2989530A (en) | Nu-(5-nitro-2-furoyl)-morpholine |